Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults

INTRODUCTION: Tenofovir disoproxil fumarate (TDF) is widely recommended for treatment of chronic hepatitis B virus (HBV) infection because it is safe, affordable and has a high genetic barrier to resistance. TDF resistance associated mutations (RAMs) have been reported, but data are limited, particu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokaya, Jolynne, Maponga, Tongai G, McNaughton, Anna L, Van Schalkwyk, Marije, Hugo, Susan, Singer, Joshua B, Sreenu, Vattipally B, Bonsall, David, de Cesare, Mariateresa, Andersson, Monique, Gabriel, Shiraaz, Taljaard, Jantje, Barnes, Eleanor, Preiser, Wolfgang, Van Rensburg, Christo, Matthews, Philippa C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408481/
https://www.ncbi.nlm.nih.gov/pubmed/32663786
http://dx.doi.org/10.1016/j.jcv.2020.104548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408481/
https://www.ncbi.nlm.nih.gov/pubmed/32663786
http://dx.doi.org/10.1016/j.jcv.2020.104548

Ejemplares similares